What's the Strategy for Stocks like Sanil Electric and Naver?

Considering recent stock price movements, it is evaluated as a blue-chip stock that does not require stop-loss.

A strategy of adding about 5% to the current weighting to lower the average purchase price can be considered. This leverages the possibility of reaching 220,000 to 250,000 won within the second half of the year.

Through this repeated trading, the effect of expanding the weighting within the box range can be achieved.

Rather than short-term responses, looking at Naver from a long-term perspective, significant growth opportunities are expected next year. Currently, the AI market is hardware and semiconductor-centric, but next year, the era of software completing its training and generating profits will arrive. Naver is the most promising company to lead the software era in Korea, and by the end of 2027 to 2028, it could see an explosive change, breaking its previous high.

It seems difficult to reach this price range immediately. If the stock price shows a rebound around 115,000 won, it is recommended to reduce some of the weighting.

When the stock price reaches a resistance zone, a strategy of reducing 3-5% or half of the holdings is necessary to cut losses. This isn't simply selling everything, but rather liquidating a portion and then repurchasing when the stock price falls again to lower the average purchase price. Through this process, more shares can be secured, increasing weighting efficiency.

A viewer purchased Jusung Engineering at 213,000 won, holding a 25% weighting.

This is because strong resistance is expected near the previous high. While expectations for Atomic Layer Deposition (ALD) equipment are high, a strategy of re-entry after confirming actual orders and revenue visibility is effective.

However, since short-term upward momentum driven by expectations may occur, it is advisable to maintain a strategy of reducing weighting during short-term stock price increases until actual performance is confirmed. The perspective that Jusung Engineering will earn more money and gain momentum will only form when actual revenue and profitability are verified.

Expressed regret for missing the selling timing, despite lowering the average purchase price through dollar-cost averaging during a stock price decline.

PharmaResearch's stock price surged in August due to strong overseas sales of its Rejuran brand but adjusted due to the overall cosmetics sector's exchange rate depreciation. However, the company's earnings momentum remains valid, and the stock price is likely to rebound around the time of the Q3 or Q4 earnings announcements. A stock price increase could occur again around this time.

A strategy of adding about 5% to the current 10% weighting to lower the average purchase price can be considered. This strategy aims for a profit-taking zone where the stock price rebounds above the purchase price.

It tends to rise only after major stocks like Doosan Enerbility or BH move first. Strong resistance is formed around 8,400 won, and caution is advised regarding a 'sell-on-the-news' phenomenon after the US investment announcement.

Recommended stronger stocks include BH or KEPCO E&C. Since a stock price adjustment is expected after the US investment announcement, this strategic approach is necessary.